 Yes. You know, when you're working clinically, it's hard to make generalizations. You can just see what's in front of you. And it certainly became a much more apparent thing that people were having these more aggressive cancers. They weren't responding to conventional therapies as well. I mean, they were certainly coming in with, I mean, typically someone would come in with stage 2 or maybe stage 3 cancer.